Literature DB >> 26021848

Simultaneous determination of acetylpuerarin and puerarin in rat plasma by liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study following intravenous and oral administration.

Deqing Sun1, Aiying Xue2, Jing Wu3, Bin Zhang3, Jinlong Yu3, Qiang Li3, Chao Sun3.   

Abstract

A rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the simultaneous determination of acetylpuerarin (AP) and its major metabolite puerarin (PUE) in rat plasma using genistein as the internal standard (IS). Plasma samples were pretreated by protein precipitation with a mixture of methanol and acetonitrile. Chromatographic separation was performed on a CAPCELL PAK C18 MGШ column with a mixture of 0.1% formic acid in water and methanol (35:65, v/v) as the mobile phase. The analytes were detected using a tandem mass spectrometer in the positive ionization and multiple-reaction monitoring mode. The ion transition of m/z 669.4→627.3, 417.5→297.6 and 271.3→153.0 was utilized to quantify AP, PUE and the IS, respectively. The calibration curves showed good linearity over the plasma concentration range of 1-2000ng/mL for AP and 2.5-5000ng/mL for PUE. The intra- and inter-day precisions (RSD %) for each analyte were less than 6.91%, and the accuracies ranged from -2.17% to 2.93%. The validated LC-MS/MS method was further successfully applied to a pharmacokinetic study of AP and PUE in rats following intravenous and oral administration.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylpuerarin; LC–MS/MS; Pharmacokinetics; Puerarin

Mesh:

Substances:

Year:  2015        PMID: 26021848     DOI: 10.1016/j.jchromb.2015.05.009

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.

Authors:  Deqing Sun; Aiying Xue; Bin Zhang; Xia Xue; Jie Zhang; Wenjie Liu
Journal:  Drug Des Devel Ther       Date:  2016-06-21       Impact factor: 4.162

2.  A Novel Microspheres Formulation of Puerarin: Pharmacokinetics Study and In Vivo Pharmacodynamics Evaluations.

Authors:  Xiao Song; Xihui Bai; Shiyu Liu; Linjuan Dong; Hui Deng; Changli Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-29       Impact factor: 2.629

3.  Upregulation of UDP-Glucuronosyltransferases 1a1 and 1a7 Are Involved in Altered Puerarin Pharmacokinetics in Type II Diabetic Rats.

Authors:  Songtao Dong; Maofan Zhang; Huimin Niu; Kunyu Jiang; Jialei Jiang; Yinglin Ma; Xin Wang; Shengnan Meng
Journal:  Molecules       Date:  2018-06-20       Impact factor: 4.411

4.  Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA.

Authors:  Hui Kong; Xueqian Wang; Rongfeng Shi; Yan Zhao; Jinjun Cheng; Xin Yan; Xiaoman Liu; Yongzhi Wang; Meiling Zhang; Qingguo Wang; Huihua Qu
Journal:  Molecules       Date:  2017-06-05       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.